Finance Home - My Yahoo - Yahoo! - Help

Tuesday, December 1, 2009, 7:22AM ET - U.S. Markets open in 2 hours and 8 minutes. Dow  0.34% Nasdaq  0.00%

Cephalon Inc. (CEPH)

On Nov 30: 54.95   0.00 (0.00%)

MORE ON CEPH

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Today, Tue, Dec 1, 2009 • Mark Hulbert: A dirty dozen at MarketWatch (Tue 12:01am) Fri, Nov 27, 2009 • [$$] Sorting Through the Stock Laggards of 2009 at Barrons.com (Fri, Nov 27) Wed, Nov 25, 2009 • Cephalon Settles Barr Challenge Zacks.com (Wed, Nov 25) Tue, Nov 24, 2009 • [$$] Stocks in the Spotlight Monday at Barrons.com (Tue, Nov 24) • H-P: Analysts' Upgrades, Downgrades at TheStreet.com (Tue, Nov 24) • Cephalon upgraded by Jefferies & Co Briefing.com (Tue, Nov 24) • [$$] Verizon Advances 3%; Chevron, Exxon Rise at The Wall Street Journal Online (Tue, Nov 24) Mon, Nov 23, 2009 • CEPHALON INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and E EDGAR Online (Mon, Nov 23) • [$$] The Good News and the Bad News at The Wall Street Journal Online (Mon, Nov 23) • Monday Options Recap at Seeking Alpha (Mon, Nov 23) • Nov. 23: Unusual Volume Leaders at CNBC (Mon, Nov 23) • UPDATE - Cephalon stock drops after mixed drug trial data at Reuters (Mon, Nov 23) • Early-Market Movers: Origin Agritech Limited, Ciena Corp at Fox Business (Mon, Nov 23) • Drug stocks advance; Cephalon falls on study at MarketWatch (Mon, Nov 23) • A Big Upgrade for Allos Therapeutics at Motley Fool (Mon, Nov 23) • Mixed results from Ception, Cephalon on Cinquil at bizjournals.com (Mon, Nov 23) • Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis PR Newswire (Mon, Nov 23) Sun, Nov 22, 2009 • Valeant may fall if new drug disappoints-Barron's at Reuters (Sun, Nov 22) Fri, Nov 20, 2009 • Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research Analyst Wall Street Transcript (Fri, Nov 20) Thu, Nov 19, 2009 • CEPHALON INC Files SEC form 8-K, Other Events EDGAR Online (Thu, Nov 19) Older Headlines - Download Recent Headlines View headlines from: Thu, Nov 19, 2009Thu, Nov 12, 2009Thu, Nov 5, 2009Thu, Oct 29, 2009Thu, Oct 22, 2009Thu, Oct 15, 2009Thu, Oct 8, 2009Thu, Oct 1, 2009Thu, Sep 24, 2009Thu, Sep 17, 2009 Add CEPH News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage